Cite
Lorenz E, Hagen B, Himmelmann A, et al. A phase II study of biweekly administration of paclitaxel in patients with recurrent epithelial ovarian cancer. Int J Gynecol Cancer. 1999;9(5):373-376doi: 10.1046/j.1525-1438.1999.99046.x.
Lorenz, E., Hagen, B., Himmelmann, A., Kjørstad, K., Onsrud, M., Tingulstad, S., & Gundersen, G. (1999). A phase II study of biweekly administration of paclitaxel in patients with recurrent epithelial ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 9(5), 373-376. https://doi.org/10.1046/j.1525-1438.1999.99046.x
Lorenz, E., et al. "A phase II study of biweekly administration of paclitaxel in patients with recurrent epithelial ovarian cancer." International journal of gynecological cancer : official journal of the International Gynecological Cancer Society vol. 9,5 (1999): 373-376. doi: https://doi.org/10.1046/j.1525-1438.1999.99046.x
Lorenz E, Hagen B, Himmelmann A, Kjørstad K, Onsrud M, Tingulstad S, Gundersen G. A phase II study of biweekly administration of paclitaxel in patients with recurrent epithelial ovarian cancer. Int J Gynecol Cancer. 1999 Sep;9(5):373-376. doi: 10.1046/j.1525-1438.1999.99046.x. PMID: 11240796.
Copy
Download .nbib